Hepatitis Monthly

Published by: Kowsar

Prevalence and Risk Factors of Hepatitis C Virus Infection in Amol City, North of Iran: A Population-Based Study (2008-2011)

Farhad Zamani 1 , Masoudreza Sohrabi 1 , * , Hossein Poustchi 2 , Hossein Keyvani 3 , Fatemeh Sima Saeedian 1 , Hossein Ajdarkosh 1 , Mahood Khoonsari 1 , Gholamreza Hemmasi 1 , Maziar Moradilakeh 1 , Nima Motamed 1 and Masoumeh Maadi 1
Authors Information
1 Gastrointestinal and Liver Diseases Research Center (GILDRC), Iran University of Medical Sciences, Tehran, IR Iran
2 Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran,IR Iran
3 Department of Virology, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Hepatitis Monthly: December 01, 2013, 13 (12); e13313
  • Published Online: December 7, 2013
  • Article Type: Research Article
  • Received: July 1, 2013
  • Revised: August 14, 2013
  • Accepted: October 21, 2013
  • DOI: 10.5812/hepatmon.13313

To Cite: Zamani F, Sohrabi M, Poustchi H, Keyvani H, Saeedian F S, et al. Prevalence and Risk Factors of Hepatitis C Virus Infection in Amol City, North of Iran: A Population-Based Study (2008-2011), Hepat Mon. 2013 ; 13(12):e13313. doi: 10.5812/hepatmon.13313.

Abstract
Copyright © 2013, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Fallahian F, Najafi A. Epidemiology of hepatitis C in the Middle East. Saudi J Kidney Dis Transpl. 2011; 22(1): 1-9[PubMed]
  • 2. Lavanchy D. The global burden of hepatitis C. Liver Int. 2009; 29 Suppl 1: 74-81[DOI][PubMed]
  • 3. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005; 5(9): 558-67[DOI][PubMed]
  • 4. European Association for the Study of the Liver . EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol. 2011; 55(2): 245-64[DOI][PubMed]
  • 5. Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, Alomair A, et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int. 2011; 31 Suppl 2: 61-80[DOI][PubMed]
  • 6. Ameen R, Sanad N, Al-Shemmari S, Siddique I, Chowdhury RI, Al-Hamdan S, et al. Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion. 2005; 45(12): 1973-80[DOI][PubMed]
  • 7. Daw MA, Dau AA. Hepatitis C virus in Arab world: a state of concern. Sci World J. 2012; 2012: 719494[DOI][PubMed]
  • 8. Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol. 2008; 48(1): 148-62[DOI][PubMed]
  • 9. Khedmat H, Fallahian F, Abolghasemi H, Alavian SM, Hajibeigi B, Miri SM, et al. Seroepidemiologic study of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and syphilis infections in Iranian blood donors. Pak J Biol Sci. 2007; 10(24): 4461-6[PubMed]
  • 10. Rezvan H, Abolghassemi H, Kafiabad SA. Transfusion-transmitted infections among multitransfused patients in Iran: a review. Transfus Med. 2007; 17(6): 425-33[DOI][PubMed]
  • 11. Shakeri MT, Nomani H, Ghayour Mobarhan M, Sima HR, Gerayli S, Shahbazi S, et al. The prevalence of hepatitis C virus in mashhad, iran: a population-based study. Hepat Mon. 2013; 13(3)[DOI][PubMed]
  • 12. Makhlough A, Jamshidi M, Mahdavi MR. Hepatitis C prevalence studied by polymerase chain reaction and serological methods in haemodialysis patients in Mazandaran, Iran. Singapore Med J. 2008; 49(11): 921-3[PubMed]
  • 13. Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR, et al. Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int J Infect Dis. 2010; 14 Suppl 3-6[DOI][PubMed]
  • 14. Poorolajal J, Mirzaei M, Bathaei SJ, Majzoobi MM. Hepatitis B and C Infections in Hamadan Province during 2004-2009. J Res Health Sci. 2011; 11(1): 51-7[PubMed]
  • 15. Ebadi M, Yaghobi R, Geramizadeh B, Bahmani MK, Malek-Hosseini SA, Nemayandeh M. Prevalence of HCV and HGV infections in Iranian liver transplant recipients. Transplant Proc. 2011; 43(2): 618-20[DOI][PubMed]
  • 16. Alavian SM, Kabir A, Ahmadi AB, Lankarani KB, Shahbabaie MA, Ahmadzad-Asl M. Hepatitis C infection in hemodialysis patients in Iran: a systematic review. Hemodial Int. 2010; 14(3): 253-62[DOI][PubMed]
  • 17. Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion. 2009; 49(10): 2214-20[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments